TR201717703A2 - Api̇ksaban formülasyonlari - Google Patents

Api̇ksaban formülasyonlari Download PDF

Info

Publication number
TR201717703A2
TR201717703A2 TR2017/17703A TR201717703A TR201717703A2 TR 201717703 A2 TR201717703 A2 TR 201717703A2 TR 2017/17703 A TR2017/17703 A TR 2017/17703A TR 201717703 A TR201717703 A TR 201717703A TR 201717703 A2 TR201717703 A2 TR 201717703A2
Authority
TR
Turkey
Prior art keywords
apixaban
formulations
apixaban formulations
prevention
pharmaceutically acceptable
Prior art date
Application number
TR2017/17703A
Other languages
English (en)
Inventor
Ünlü Serdar
Şahi̇n Yasemi̇n
Muhi̇bbi̇ Işik Murat
Soyer Can Okşan
Göçmentürk Mustafa
Eryalçin Özlem
Kazaz Çağla
Original Assignee
Ali Raif Ilac Sanayi Ve Ticaret Anonim Sirketi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ali Raif Ilac Sanayi Ve Ticaret Anonim Sirketi filed Critical Ali Raif Ilac Sanayi Ve Ticaret Anonim Sirketi
Priority to TR2017/17703A priority Critical patent/TR201717703A2/tr
Publication of TR201717703A2 publication Critical patent/TR201717703A2/tr

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Mevcut buluş apiksaban veya farmasötik olarak kabul edilebilir bir tuzunu içeren oral farmasötik formülasyonlar için üretim yöntemine ve bu yöntemle üretilen formülasyonların tromboembolik hastalıkların önlenmesinde ve/veya tedavi edilmesinde kullanılmasına ilişkindir.
TR2017/17703A 2017-11-10 2017-11-10 Api̇ksaban formülasyonlari TR201717703A2 (tr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TR2017/17703A TR201717703A2 (tr) 2017-11-10 2017-11-10 Api̇ksaban formülasyonlari

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2017/17703A TR201717703A2 (tr) 2017-11-10 2017-11-10 Api̇ksaban formülasyonlari

Publications (1)

Publication Number Publication Date
TR201717703A2 true TR201717703A2 (tr) 2019-05-21

Family

ID=67954923

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2017/17703A TR201717703A2 (tr) 2017-11-10 2017-11-10 Api̇ksaban formülasyonlari

Country Status (1)

Country Link
TR (1) TR201717703A2 (tr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022010437A1 (en) * 2020-07-07 2022-01-13 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi A tablet comprising apixaban
WO2022115051A1 (en) 2020-11-27 2022-06-02 Santa Farma Ilac Sanayii A.S. Direct compression method for non-micronised apixaban formulations
WO2022115052A1 (en) 2020-11-27 2022-06-02 Santa Farma Ilac Sanayii A.S. Improved wet granulation processes for apixaban comprising formulations

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022010437A1 (en) * 2020-07-07 2022-01-13 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi A tablet comprising apixaban
WO2022115051A1 (en) 2020-11-27 2022-06-02 Santa Farma Ilac Sanayii A.S. Direct compression method for non-micronised apixaban formulations
WO2022115052A1 (en) 2020-11-27 2022-06-02 Santa Farma Ilac Sanayii A.S. Improved wet granulation processes for apixaban comprising formulations

Similar Documents

Publication Publication Date Title
ZA202202711B (en) Sustained-release dosage forms of ruxolitinib
MX2024010140A (es) Nuevos metodos.
NZ762034A (en) Human plasma kallikrein inhibitors
JO3122B1 (ar) مشتقات إسترا-5،3،1(10)، 16- تترايين-3- كربوكساميد، عمليات لتحضيرها، مستحضرات دوائية تشتمل عليها واستخدامها لتحضير أدوية
MA39765A (fr) Formulation pharmaceutique d'un inhibiteur de la kinase pan-raf, ses procédés de préparation, et procédés d'utilisation
EA201500112A1 (ru) 3-замещенные производные эстра-1,3,5(10),16-тетраена, способы их получения, фармацевтические средства, которые их содержат, и их использование для получения лекарственных средств
MX394123B (es) Compuestos amidas, composiciones farmacéuticas de estos y métodos para utilizarlos
MX387731B (es) Composiciones farmacéuticas orales de mesalazina.
EA201692111A1 (ru) Фармацевтические композиции, содержащие данириксин, для лечения инфекционных заболеваний
EA201691796A1 (ru) П-замещенные асимметричные мочевины и их применение в медицине
EA201692020A1 (ru) Пролекарственные средства янтарной кислоты для применения в лечении лактоацидоза или индуцируемого лекарственными средствами побочного действия вследствие связанных с комплексом i нарушений окислительного фосфорилирования в митохондриях
EA202090913A1 (ru) Композиция таблеток с модифицированным высвобождением, содержащая мирабегрон
TR201717703A2 (tr) Api̇ksaban formülasyonlari
PH12016502568B1 (en) Novel heterocyclic compound
CY1123394T1 (el) Φαρμακευτικη συνθεση
EA201892842A1 (ru) Фармацевтические композиции, включающие сафинамид
PH12016502480A1 (en) Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases
TR201713326A2 (tr) Rivaroksaban İçeren Formülasyonlar İçin Üretim Yöntemi
TR201713325A2 (tr) Ri̇varoksaban i̇çeren formülasyonlar i̇çi̇n üreti̇m yöntemi̇
JOP20200005A1 (ar) تركيبات صيدلية
MX375329B (es) 2,2,2-trifluoroetil-tiadiazinas.
TR201719926A2 (tr) Farmasöti̇k olarak kabul edi̇lebi̇li̇r li̇tyum tuzlari ve c vi̇tami̇ni̇ i̇çeren farmasöti̇k bi̇leşi̇mler
PH12019501070A1 (en) Sustained-release dosage forms of ruxolitinib
EA201892675A1 (ru) Фармацевтическая композиция, содержащая этеплирсен
EA201790387A1 (ru) Фармацевтическая композиция для лечения острой зубной боли или боли в челюсти